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Abstract 1 
Proteases with important roles for bacterial pathogens which specifically reside 2 
within intracellular vacuoles are frequently homologous to those which have 3 
important virulence functions for other bacteria. Research has identified that 4 
some of these conserved proteases have evolved specialised functions for 5 
intracellular vacuole residing bacteria. Unique proteases with pathogenic 6 
functions have also been described from Chlamydia, Mycobacteria, and 7 
Legionella. These findings suggest that there are further novel functions for 8 
proteases from these bacteria which remain to be described. This review 9 
summarises recent findings of novel protease functions from the intracellular 10 
human pathogenic bacteria which reside exclusively in vacuoles. 11 
 12 
Introduction 13 
Bacterial pathogens display a wide array of tissue trophisms and disease pathologies 14 
in humans, including intracellular growth for many pathogens. Most intracellular 15 
pathogens have at least a transient association with a vacuole as they are frequently 16 
taken into the cell via an endocytic or phagocytic vacuole, however only a select few 17 
remain associated with this vacuole. Many others escape to, or directly enter, the 18 
cytosol where they replicate, including Burkholderia, Shigella, Francisella tularensis, 19 
Listeria monocytogenes, and Porphymonas gingivalis. In order to be successful within 20 
the intracellular vacuole the bacteria must manipulate the host cell to develop and 21 
protect the vacuole. Bacterial proteases have critical roles for this pathogen:host cell 22 
interface. This review highlights the recent exciting advances in the understanding of 23 
the important roles that proteases conduct for bacterial pathogens which require a 24 
intracellular vacuole for successful pathogenesis.  25 
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 1 
A. Proteases and Bacterial Pathogenesis 2 
 3 
Proteases are known to have crucial roles for all domains of life with functions such 4 
as protein processing, cellular functions, signalling, protein maintenance, protein 5 
degradation, and liberation of amino acids and have long been implicated in bacterial 6 
virulence. It is clear that the specific tissue or niche pathogenic environment of the 7 
pathogen directly influences the proteolytic arsenal. An example is the suite of 8 
proteases secreted by Porphyromonas gingivalis (the major etiological agent for 9 
periodontitis) which have been implicated in the tissue destruction which results in the 10 
disease pathology (Kumagai, et al., 2005).  11 
Intracellular bacterial pathogens often enter cells via endocytosis, followed by 12 
rapid escape to the cytoplasm to avoid the lysosomal pathway, or for a specialised 13 
group of bacteria, by the establishment of a specific vacuole in which the bacteria 14 
reside and replicate. Whilst the composition and localisation of these vacuoles are 15 
distinct to each bacterial species, the biogenesis of the vacuole commonly involves 16 
both bacterial and host factors. The bacteria manipulate the host cell from within this 17 
vacuole; to maintain the integrity of the vacuole, to repress or induce apoptotic and 18 
immune signally pathways, to manipulate host cell cytoskeleton, influence cell 19 
division, and ensure nutrient supply. There have been a number of comprehensive 20 
reviews of host-pathogen interactions and the variety of different bacterial effectors 21 
involved in this relationship, including (Knodler, et al., 2001, Bhavsar, et al., 2007, 22 
Faherty & Maurelli, 2008, Hybiske & Stephens, 2008).  23 
 24 
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B. Bacterial pathogens which replicate and reside within intracellular 1 
vacuoles 2 
 3 
There are only six bacterial pathogens which have been described to remain within a 4 
vacuole for intracellular replication and survival. For the purpose of this review 5 
vacuole resident bacterial pathogens have been defined as: those bacteria which 6 
remain intimately associated with, and replicate within, a vacuole for the majority of 7 
their intracellular phase either in all or some cell types. The human bacterial 8 
pathogens which fit this definition include; Chlamydia, Salmonella, Brucella, 9 
Legionella, Coxellia, and Mycobacterium. In order to consider the role of proteases 10 
for these intracellular vacuole pathogens, it is important to firstly consider the unique 11 
vacuole niche in which these bacteria reside (summarised Fig 1). 12 
 13 
1. Salmonella enterica serovar Typhimurium 14 
Salmonella enterica serovar Typhimurium is a facultative intracellular pathogen 15 
which causes gastroenteritis in humans. The organism encodes two type III secretion 16 
systems which inject proteins into the host cell to facilitate invasion and biogenesis of 17 
the vacuole (SCV, Salmonella containing vacuole)(Brawn, et al., 2007), recently a 18 
third type III secretion system encoding a flagella has been described to have an 19 
intracellular role, by direct export of flagella components into the host cell to induce a 20 
pro-inflammatory response (Hautefort, et al., 2008). The vacuole, which has been 21 
described as a stalled late endocytic/lysosomal vesicle, is located close to the golgi 22 
apparatus (Ramsden, et al., 2007). Global gene changes observed during different 23 
phases of intracellular infection and dependent on the cell type (epithelial or 24 
macrophage) suggest Salmonella is a versatile intracellular pathogen (Hautefort, et al., 25 
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2008). In spite of the many properties which are yet to be determined Salmonella’s 1 
survival and manipulation of the host cell from the SCV has many potential areas 2 
where novel protease functions may be discovered including, the rapid assembly and 3 
removal of distinct protein machinery and factors for the different cell types they 4 
infect, and response to and survival in the potentially acidic environment of the late 5 
endosome-like vacuole.  6 
 7 
2. Brucella 8 
Brucella is a human zoonosis which causes a severe and debilitating disease in 9 
humans. Brucella are low stimulants for the human immune response due to reduced 10 
expression of pathogen associated molecular patterns (PAMPs)(Barquero-Calvo, et 11 
al., 2007). The bacteria produce far fewer classic virulence factors than most other 12 
pathogens and this successful pathogenesis is attributed to the localisation within an 13 
intracellular vacuole niche environment within a variety of phagocytic cells (reviewed 14 
(Ko & Splitter, 2003)). The vacuole maturation into a late autophagosome involves 15 
both bacterial and host factors, although little is currently known about the vacuole 16 
biogenesis (Qin, et al., 2008). The vacuole is known to inhibit fusion with lysosomes 17 
and is associated with the ER. The bacterial factors which have a role for intracellular 18 
survival include; SpoT; the ppGpp3’-pyrophosphohydrolase involved in starvation 19 
response, a type IV secretion system (VirB), cell wall synthesis, and membrane 20 
structure components (Kim, et al., 2003). The limited suite of virulence factors which 21 
have been identified for Brucella implies that either; the organism requires few 22 
virulence factors, or that it has unique virulence strategies which facilitate it’s 23 
intracellular vacuole niche that remain to be described (potentially including novel 24 
proteases).  25 
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 1 
3. Mycobacterium tuberculosis and leprae 2 
Mycobacterium tuberculosis and leprae, causative agents of tuberculosis and leprosy 3 
are responsible for considerable human disease burden worldwide. Mycobacterium, 4 
replicate within a vacuole inside phagocytes during disease, excluding 5 
Mycobacterium ulcerans which has both intracellular and extracellular phases during 6 
infection (Torrado, et al., 2007). The M. tuberculosis infected phagocytes are 7 
surrounded by a complex of inflammatory cells and material which is termed the 8 
granuloma. The aggressive immune response, which causes immunopathology and is 9 
thought to be beneficial to the pathogen by increasing transmission, is stimulated by 10 
the unique cell wall mycolic acids and other bacterial components. However, the 11 
Mycobacterium also use multiple means to specifically stimulate or down-regulated 12 
the human immune response throughout the course of disease, and are able to persist 13 
causing latent disease (reviewed (Doherty & Andersen, 2005)). The Mycobacterium 14 
vacuole resembles a stalled early endosome, as it is non-acidic and has early 15 
endosomal markers. A number of bacterial factors have been identified which mediate 16 
the development of this niche vacuole including; SecA2 secreted factors (Kurtz, et al., 17 
2006), urease, lipoarabinomannin, protein kinase G, lipid phosphotase, and cell wall 18 
cholesterol composition (Doherty & Andersen, 2005). Proteases are likely to play a 19 
variety of critical roles in this host:pathogen interaction, a likely example is the 20 
secreted mycosins, discussed further in the next section, and potentially other 21 
proteases which function in the modification of both bacterial and host proteins to 22 
pathogenic advantage.   23 
 24 
4. Legionella 25 
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Legionella are facultative intracellular pathogens, thought to naturally infect single 1 
cell protozoa such as amoebae. Legionella pneumophila is the predominant species 2 
which cause disease in humans. Legionella’s biphasic life cycle consists of 3 
morphologically distinct variants of the transmissive form (infective) and the 4 
intracellular replicative form. The replicative form is found within an intracellular 5 
vacuole in alveolar epithelia and macrophages during human disease. Legionella and 6 
the closely related pathogen Coxiella share a distinct type IV secretion system 7 
(Dot/Icm, TFSS) which exports bacterial effector proteins into the host cell 8 
cytoplasm. These bacterial effector proteins mediate development of the vacuole 9 
which traffics to the endoplasmic reticulum (ER) and avoids the lysosomal pathway 10 
(reviewed (Roy & Tilney, 2002)). The vacuole is a rich, ribosome surrounded, ER 11 
compartment. There appears to be redundancy in the bacterial genes involved in 12 
pathogenesis and intracellular survival, due to the presence of multiple homologous 13 
genes and also as genetic knockouts in many putative virulence factors do not result in 14 
attenuation of virulence. However, many factors have been implicated in virulence 15 
including; TFSS, proteases, stationary phase response RpoS, Type II secretion system 16 
and iron assimilation genes  (reviewed (Roy & Tilney, 2002)). Protease functions for 17 
this organism likely include assembly and regulation of bacterial proteins as well as 18 
specific degradation and modulation of host proteins. As it has been demonstrated that 19 
Legionella can survive early acidification of the vacuole proteases which function in 20 
stress response may also be critical to the pathogenesis of this organism. 21 
 22 
5. Coxiella 23 
Coxiella, an obligate intracellular pathogen, has many features in common with the 24 
closely related Legionella. Coxiella burnetti, a zoonotic pathogen which causes severe 25 
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flu-like disease and fever in humans, has been identified as a potential bio-terrorism 1 
agent. The organism has a biphasic life cycle, consisting of morphologically distinct 2 
extracellular environmentally stable form and an intracellular replicative form (within 3 
phagocytes during human infections). The intracellular vacuole of Coxiella is distinct 4 
from that of Legionella as it is acidic and is characteristic of a phagolysosome, 5 
although both vacuoles locate to the ER (Seshadri, et al., 2003). Co-infection 6 
demonstrated that the Legionella and Coxiella intracellular vacuoles do not fuse, even 7 
though the Coxiella vacuoles are able to fuse with other pathogenic vacuoles 8 
including Mycobacterium tuberculosis, indicating that the Legionella and Coxiella 9 
vacuoles are distinct (Sauer, et al., 2005). There is potential for unique proteases 10 
which have specific host cell targets to be identified from this organism, given the 11 
distinct vacuole development. Stress response and modification of the bacterial 12 
proteome between the two bacterial forms both have the potential to involve critical 13 
bacterial proteases. 14 
 15 
6. Chlamydia 16 
Chlamydia is an obligate intracellular pathogen, with Chlamydia pneumoniae and 17 
Chlamydia trachomatis causative agents of human disease, including pneumonia, 18 
sexually transmitted infections, and trachoma. The bacterium is not able to be 19 
genetically manipulated and is typified by a biphasic developmental cycle. The cycle 20 
consists of small, metabolically inactive, extracellular, infectious forms (EBs) and 21 
intracellular, metabolically active, non infections replicative forms (RBs). The 22 
intracellular bacteria replicate within an inclusion vacuole which seems to be entirely 23 
exclusive of the endocytic pathway. The biogenesis of the vacuole is mediated by 24 
Chlamydia interactions with host cell components, including actin, and acquisition of 25 
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9 
vesicles including golgi-derived vesicles containing sphingomyelin (reviewed, 1 
(Abelrahman & Belland, 2005)). The manipulation of many host cell pathways to 2 
provide an ideal infectious and replicative environment has been demonstrated, 3 
including pathways for, immunity, apoptosis, and cell division. Frequently these 4 
manipulations have been described to involve TTSS effectors, proteases, and 5 
GTPases, however, a number of known effects on the host cell which have been 6 
attributed to chlamydial factors remain to be mechanistically elucidated.  7 
 8 
C. Adaptation of widely conserved bacterial proteases to the 9 
specialised niche of intracellular bacterial pathogens 10 
 11 
There are numerous examples of bacterial proteases which are widely conserved 12 
throughout the domain bacteria, which have been found to have specialised substrates 13 
or functions within some species. There are a number of examples of these 14 
modifications for the intracellular vacuole resident bacteria, those with the most well 15 
characterised functions are described here. 16 
 17 
1. Cytoplasmic ATP dependent protease Lon 18 
The cytoplasmic ATP dependent protease Lon (MERNUM: MER000485), which 19 
typically functions during stress conditions, and for degradation of ssrA tagged 20 
polypeptides referred to as tmRNA or 10aRNA), is important for virulence of some 21 
pathogens. Lon, a serine protease of the Clan SJ, Family S17,  is important for 22 
motility and biofilm formation of Pseudomonas aeruginosa, both factors in the 23 
virulence of this bacterium (Marr, et al., 2007). Within the intracellular niche, Lon is 24 
essential for intracellular survival and epithelial cell invasion of Salmonella enterica 25 
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10 
(Boddicker & Jones, 2004). This is at least partially due to Lon’s function in 1 
differential regulation of the expression Salmonella pathogenicity islands during 2 
intracellular survival and intracellular infections, by degrading regulatory factors HilC 3 
and HilD (Takaya, et al., 2005). This degradation is a specific proteolytic regulatory 4 
mechanism, leading to altered transcription of the pathogenicity islands. Brucella 5 
abortus Lon has a stress survival function and a virulence role in the mouse model of 6 
infection, although the substrates of  Brucella Lon involved in mouse infection remain 7 
unknown (Robertson, et al., 2000). Given that Lon has been described to have many 8 
different functions, and regulatory roles for bacteria, this protease may have important 9 
functions for the other vacuole resident pathogens. Interestingly, there are no putative 10 
genes for lon present on either the Mycobacterium leprae or Mycobacterium 11 
tuberculosis genomes, although genes annotated as lon are present in the genomes of 12 
Chlamydia, Legionella, Coxiella, and Brucella. The Mycobacterium proteosome 13 
activity factor (described below) likely conducts similar functions to Lon. Lon has the 14 
potential to have specific regulatory roles for th  rapid removal of key proteins which 15 
may be important for these pathogens, all of which require specific alterations in their 16 
proteomes according to the specific stage of their pathogenesis (ie distinct proteins are 17 
likely required for very specific and short time frames during invasion, establishing 18 
the vacuole, and preparing to exit the host cell).  19 
 20 
2. Mycobacterium Proteasome 21 
A virulence role has also been demonstrated for the Mycobacterium proteasome 22 
(MERNUM: MER001720 and some of the accessory and co-components. Bacterial 23 
proteasomes have only been described in members of the class acintomycetes and are 24 
very reminiscent of the eukaryotic proteasomes. These proteases are large 25 
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11 
multisubunit barrel structures which consist of rings of β subunits (catalytic unit) 1 
between rings of the α subunit (Wang. T, et al., 2009). The α subunit is the ATPase 2 
(Mpa) which is critical for substrate coordination and unfolding. The catalytic subunit 3 
has a threonine catalytic residue and belongs to the protease clan PB, family T1 4 
according to MEROPs classifications. The proteasome relies on a ubiquitinylation like 5 
label for substrate determinants, termed pupylation, which is known to rely on PafA 6 
(for some substrates) (Pearce, et al., 2008), a deamidase (PafD) (Striebel, et al., 2009), 7 
and the protein which is conjugated to lysines on the substrate proteins (Pup) 8 
(reviewed (Darwin, 2009)).  Interestingly, the Mpa and accessory PafA are 9 
specifically required for in vivo growth and pathogenesis, supporting that, whilst the 10 
degradation of damaged proteins (such as those damaged by NO and other oxidants) 11 
is an important function of the mycobacterial proteasome both in vitro and in vivo, 12 
some specific substrates may be ta geted for regulation or critical proteomic 13 
modifications, in a similar scenario to that which has been elucidated for Lon in other 14 
bacteria. 15 
 16 
3. Cytoplasmic ATP dependent protease complex ClpXP 17 
The cytoplasmic ATP dependent protease complex ClpXP, (ubiquitous Clp (Hsp100) 18 
protease/chaperone family, MERNUM: MER00474) have protein maintenance, stress 19 
response and virulence roles in many bacteria. ClpP is the serine protease component 20 
(Clan SK, Family S14), and is always found with a second subunit, typically ClpA or 21 
ClpX which is the ATP binding subunit which also unfolds the substrates. These 22 
proteases have been demonstrated to assemble into 7-mer rings. A complex regulatory 23 
role of ClpXP has been described for Salmonella enterica; the protease regulates the 24 
Salmonella pathogenicity island I (SPII) TTSS. The regulation occurs via direct 25 
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12 
degradation of the flagella master regulator FliD/C, thus preventing transcription of a 1 
gene which encodes a positive regulator (FliZ) of the expression of HilC/HilD which 2 
in turn are positive regulators of the SPII (Kage, et al., 2008). Salmonella enterica 3 
clpXP mutants show reduced virulence in the mouse model of disease. Brucella suis 4 
clpAB has been demonstrated to be critical for stress survival, including the types of 5 
stress the organism is likely to encounter in vivo such as acid stress (Ekaza, et al., 6 
2001). The genome sequences for all the vacuole resident bacterial pathogens which 7 
are the focus of this Review have at least one set of clp genes annotated. This highly 8 
conserved protease is likely to be important to most intracellular and extracellular 9 
bacteria, and seems unlikely to be a source of unique intracellular adaptations, except 10 
in controlling key regulators such as described for Salmonella. 11 
 12 
4. HtrA/DegP 13 
HtrA, a temperature activated stress response protease (MERNUM: MER000266), has 14 
been identified to have a virulence role in many bacterial pathogens, by chaperoning 15 
or degrading misfolded proteins and in some cases maturation of proteins to allow 16 
correct assembly (reviewed, (Clausen, et al., 2002)). HtrA or DegP is a chymotryptic 17 
like serine protease with a C-terminal PDZ domain which functions in either gating 18 
the active site or substrate coordination depending on the family member. These 19 
proteases are frequently found as hexamers but been found in complex with substrates 20 
as 24-mers (Krojer, et al., 2008). HtrA is required for virulence of Salmonella 21 
enterica (Lowe, et al., 1999). Interestingly, both the chaperone and protease function 22 
of HtrA were important for virulence of Salmonella, although protease activity was 23 
more important (Lewis, et al., 2009). HtrA related proteases DegQ and DegS also 24 
contribute to Salmonella virulence (Farn & Roberts, 2004, Mo, et al., 2006). 25 
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13 
Legionella HtrA is critical for virulence in mammalian cells and virulence in the AJ 1 
mouse intrapulmonary infection model (Pedersen, et al., 2001, Clausen, et al., 2002). 2 
Brucella HtrA has been demonstrated to be functionally active, with conflicting 3 
reports on an intracellular requirement, although there is consensus that HtrA is 4 
important for Brucella infection of macrophages in vitro (Elzer, et al., 1996, Phillips 5 
& Roop, 2001, Roop, et al., 2001, Kim, et al., 2003). HtrA related proteases DegQ 6 
and DegS also contribute to Salmonella virulence (Farn & Roberts, 2004, Mo, et al., 7 
2006). Chlamydia HtrA has been demonstrated to be functionally active and present at 8 
different levels during intracellular infection model which could imply a role for 9 
pathogenesis (Huston, et al., 2007, Huston, et al., 2008). There are three predicted 10 
htrA for Mycobacterium tuberculosis (although in this publication no account for 11 
likely DegS and DegQ homologs has been noted, thus we suggest there may be one 12 
HtrA, one DegS, and one DegQ) and one of these, HtrA2, was been shown to be 13 
important for virulence in the mouse model (Mohamedmohaideen, et al., 2008). The 14 
HtrA encoded on the Coxiella genome could prove to have a virulence role given the 15 
likely high protein stress conditions within the late endo-lysosomal vacuole in which 16 
these bacteria reside. A virulence function of HtrA has been demonstrated for many 17 
bacteria with considerable diversity of pathogenic niche, and while little is known 18 
about the specific substrates of HtrA, the virulence function seems to be due to both 19 
the stress response proteolytic activity and protein assembly/chaperone activity for 20 
assembly of extra-cytoplasmic proteins (Skorko-Glonek, et al., 1995, Krojer, et al., 21 
2002, Skorko-Glonek, et al., 2007). This suggests that while the function of HtrA is 22 
unlikely to show unique adaptations to the intracellular niche, the chaperone 23 
substrates may be distinct between the vacuole resident and non vacuole resident 24 
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14 
bacterial pathogens and represent key determinants for surviving the intracellular 1 
vacuole niche.   2 
 3 
5. DegS and Site 2 Protease 4 
The proteolytic signal cascade which upregulates htrA and other cell envelope stress 5 
response components in E. coli involves HtrA related protease DegS (MERNUM: 6 
MER001373) and the inner membrane Site 2 protease zinc metalloprotease RseP 7 
(MERNUM: MER004480). The components of this pathway are conserved and likely 8 
conduct a similar function in Salmonella. Mycobacteria PepD which is one of the 9 
three HtrAs, have recently been identified to participate in upregulation of SigmaE 10 
during stress, supporting a similar regulatory network in this organism (White, et al., 11 
2010). Analysis of the Legionella, Coxiella, and Brucella genomes are supportive of a 12 
potentially similar proteolytic signalling pathway, with many constituents conserved; 13 
particularly DegS and RseP, although none of these have been functionally 14 
demonstrated. The Chlamydia genome encod s a site 2 protease homolog but no 15 
DegS homolog suggesting the site 2 protease may be involved in an alternative 16 
proteolytic function in this organism. The site 2 protease homolog on the 17 
Mycobacterium tuberculosis genome (RseP) has been shown to be involved in a 18 
proteolytic signal regulating the unique cell envelope composition of Mycobacterium, 19 
including mycolic acid content (Makinoshima & Glickman, 2007). The role of 20 
proteolytic signalling cascades for bacterial pathogens have not been well described 21 
and the site 2 protease mediated signalling cascade could play vital and unique roles 22 
in the pathogenesis of these intracellular bacteria. 23 
 24 
6. Tail specific protease 25 
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The tail specific protease (Tsp, MERNUM: MER001295) was first described in E. 1 
coli as a periplasmic protease important for C-terminal processing of substrates 2 
including PBP3 or FtsI. The protease is a serine protease of the clan SK family S41 3 
which cleaves protein substrates at the C-terminus. There have been few 4 
investigations into Tsp from other bacteria although recently a protein processing role 5 
in Borrelia borgdeferi was demonstrated (Ostberg, et al., 2004). The Brucella suis 6 
Tsp has a role in cellular morphology suggesting a similar protein processing 7 
function, and is important for virulence and intracellular survival (Bandara, et al., 8 
2005). Tsp has been shown to have a completely novel function in Chlamydia 9 
whereby it is exported into the host cell and degrades the protein p65 thus preventing 10 
NF-κβ activation of a variety of inflammatory genes (Lad, et al., 2007, Lad, et al., 11 
2007). No functional analysis has been reported of the Tsp homologs which are 12 
present on the genomes of Legionella, Coxiella, Salmonella and no Tsp homolog is 13 
present on the genomes of Mycobacterium. This highly specialised role of this widely 14 
conserved protease for Chlamydia demonstrates that the intracellular-vacuole-resident 15 
bacteria are a source of novel protease adaptations, even from conserved proteases. 16 
 17 
7. Deubiquitinases 18 
Only a few pathogens have been shown to produce deubiquitinases, including herpes 19 
virus, Yersinia, Burkholderia and of interest to this review, Salmonella and 20 
Chlamydia. Chlamydia was detected to have two ubiquitinases, using an activity 21 
based probe (Misaghi, et al., 2006). The deubiquitinases are cysteine proteases which 22 
specifically hydrolyse mono- or poly-ubiquitinated substrates, the substrates can be 23 
highly specific, meaning that deubquitinases can generally prevent degradation of 24 
substrates or conduct specific regulatory functions.  The deubiquitinases are a likely 25 
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component of the other vacuole resident pathogens proteolytic suite, and are 1 
potentially likely to have unique roles in vacuole development in maintenance as the 2 
vacuoles for some of these pathways are derived from manipulations of innate 3 
immunity. This role would be unlike the extra-vacuole pathogens where 4 
manipulations of the innate immune signalling pathways are more likely to be 5 
targeted towards reduced surveillance and reduced secretion of innate immune 6 
mediators. 7 
a. Chlamydia ChlaDub1 8 
One of the deubiquitinases, ChlaDub1 (CT868, MERNUM: MER011029), was shown 9 
to suppress NF-κβ activation by binding to IκBα and inhibiting ubiquination, whilst 10 
proteolytic activity is not associated with this suppression; the catalytic domain alone 11 
was able to inhibit ubiquitination (Le Gegrate, et al., 2008).  12 
b. Salmonella SseL 13 
NF-kb components appears to be a key substrate of the pathogenic ubiquitinases, as 14 
the Salmonella deubiquitinase (SseL) also de-ubiquitinated IκBα to prevent NF-κβ 15 
activation.  16 
c. Yersinia YopJ 17 
The Yersinia deubiquitinase, YopJ, was demonstrated to have many substrates IκBα  18 
was also a key substrate (Zhou, et al., 2005).  19 
 20 
 21 
D. Pathogenesis proteases with specialised virulence functions for the 22 
vacuole resident bacterial pathogens 23 
The specialised niche of these bacteria within the host cell environment means that 24 
they have evolved some highly specific and novel proteases, the best characterised 25 
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examples of these are described here. These proteases are often mechanistically 1 
related to the conserved proteases but have evolved distinct substrates or roles for the 2 
intracellular niche. These exciting findings support that many more novel proteases 3 
will be uncovered from this niche.  4 
 5 
1. Chlamydia protease-like activity factor 6 
The Chlamydia protease-like activity factor (CPAF, MERNUM: MER028784), is a 7 
serine protease which is completely novel to Chlamydia and shows some homology to 8 
the C-terminal sequence of Chlamydia Tsp. CPAF was detected by the proteolytic 9 
activity for degradation of transcription factors (RFX5 and USF-1) which upregulate 10 
major histocompatibility complex molecules and plays a major role in the cytotoxicity 11 
of this pathogen (Zhong, et al., 1999, Zhong, et al., 2000). CPAF is also indirectly 12 
responsible for the cleavage of host cell BH3, which prevents the upregulation of 13 
apoptosis (Pirbhai, et al., 2006).  All members of the chlamydiae, including a distantly 14 
related organism amoebal endosymboint protochlaydia amoebephila have a CPAF, 15 
suggesting that CPAF may have originally evolved for a non-immune target, such as 16 
the cytoskeleton proteins which it has been shown to cl ave (including keratin 8, and 17 
vimentin) (Dong, et al., 2004, Paschen, et al., 2008). The protein is mechanistically 18 
related to the tricorn protease (serine catalytic residue, clan SK, family S41) although 19 
it is likely that this protease has evolved from gene duplication of Tsp as its protease 20 
domain is most closely related to the Chlamydia Tsp protease domain. CPAFs 21 
mechanism is somewhat reminiscent of the caspases as it is synthesised as a precursor 22 
and in a concentration dependent mechanism trans-autocatalysis removes an 23 
inhibitory loop which allows activation of the homodimer protease (Huang, et al., 24 
2008).  25 
Page 19 of 37
ScholarOne Support 1-434/817-2040 ext 167
FEMS Immunology and Medical Microbiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
18 
 1 
2. Exported metalloproteases – Legionella MspA/ProA 2 
Exported metalloproteases have long been the focus of research efforts for Legionella 3 
and has been demonstrated that the major secreted zinc metalloprotease (MspA/ProA, 4 
MERNUM: MER001039) of Legionella has a host of virulence roles, including 5 
cleavage of various immune molecules (including IL2), and processing of bacterial 6 
factors, however, it is not essential for virulence (Moffat, et al., 1994, Rossier, et al., 7 
2008). The protease has been demonstrated to be an active protease of the Clan MA, 8 
Family M4 class, and may yet have critical virulence functions, as there is numerous 9 
metalloproteases of the same class and other metalloproteases encoded on the genome 10 
of Legionella which would allow for redundancy. A diverse range of metalloproteases 11 
are present on the genomes of all the intracellular bacterial vacuole pathogens, and are 12 
likely to conduct a variety of processes, including as exported proteases with specific 13 
host cell targets. 14 
 15 
3. Plasminogen activator protease - Legionella 16 
A Plasminogen activator protease, Pla, homologous to that from Yersinia pestis has 17 
been described from Legionella pneumophila (Vranckx, et al., 2007). The surface 18 
located protease was demonstrated to be important for survival within amoebae and 19 
likely has a distinct function from the Yersinia homolog (which is thought to facilitate 20 
invasion through endothelia) given the different pathogenic lifestyles of these two 21 
organisms. 22 
 23 
4. Subtilisin-like serine proteases – Mycobacterium 24 
a. Mycosin 25 
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The presence of five putative exported subtilisin-like serine proteases (mycosins) 1 
(clan S8, family S8 MEROPS classification) on the genome of Mycobacterium 2 
tuberculosis has been reported (Dave, et al., 2002). The role of these proteases 3 
remains unknown although one (mycosin-1; MERNUM: MER003060) was 4 
demonstrated to be cell wall and culture media associated. These mycosins may have 5 
a function in the modifications of the cell wall of Mycobacteria during the different 6 
stages of cellular invasion or even between acute and persistent phases, another 7 
function which it is tempting to speculate could be for the targeted release of cell wall 8 
compounds to stimulate the immune response and facilitate development of the 9 
granuloma.   10 
 11 
b. Cell wall protease Rv2224c 12 
Mycobacterium also produces a cell wall protein (serine protease Rv2224c; annotated 13 
as a dipeptidylpeptidase), which has been biochemically demonstrated to have 14 
esterase activity, however, a direct role of this protein in secretion of two forms of 15 
GroEL has been demonstrated which supports that it is a protease. Rc2224c mutants 16 
were impaired for virulence, intracellular survival, resistance to immune compounds, 17 
and showed reduced resistance to cell wall stressors (Rengarajan, et al., 2008).  18 
 19 
c. Transmembrane serine protease Rv3671c 20 
A putative transmembrane serine protease (Rv3671c, MEROPS PA Clan S1) from 21 
Mycobacterium tuberculosis was described to have a critical role in the acid resistance 22 
required for the organism to survive the acidification of the phagosome in activated 23 
macrophages. Rv3671c mutants were impaired for virulence and persistence in an in 24 
vivo mouse model (Vandal, et al., 2008). However, the biochemical mechanism of 25 
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this protease and it’s substrates remain to be characterised although it seems most 1 
likely to have a role in cell wall integrity.   2 
 3 
 4 
III. Conclusions 5 
 6 
The intracellular vacuole resident bacterial pathogens share many crucial virulence 7 
components, including proteases, with their extracellular and cytoplasmic bacterial 8 
relatives. The distinct niche environments of each of these pathogens will clearly have 9 
differing requirements for proteases. Proteases which function for stress protection, 10 
nutrient acquisition, regulation, cell division, and growth are all likely to be important 11 
for these pathogens similarly to other pathogens. Highly specific manipulations of 12 
host cell pathways to develop and maintain the vacuole niche environment and 13 
supportive host cell conditions also likely involves specialised bacterial proteases 14 
which remain to be characterised. However, the finding of novel adaptations of both 15 
conserved and pathogenic specific proteases described here support that there are 16 
likely further novel proteases from these bacteria. Future experimental analysis of 17 
both the conserved and unique proteases found within each of these bacterial 18 
pathogens will provide insights into bacterial pathogenesis and likely uncover novel 19 
mechanisms for host-pathogen interaction to pathogenic advantage. 20 
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 1 
 2 
Fig 1. A schematic figure showing the highly specialised niche vacuoles of the 3 
intracellular vacuole resident bacteria. The vacuole properties are indicated in the 4 
boxes. The Salmonella vacuole is effectively a late endocytic-lysosomal vacuole 5 
which is typified by long branching structures termed Salmonella induced filaments 6 
(sif). These filaments align with cytoskeletal components and the vacuole is typically 7 
surrounded by exocytic golgi vesicles. The Brucella vacuole is an autophagosome 8 
located at endoplasmic reticulum export sites, with a number of autophagosomal and 9 
ER markers on the vacuole. The Chlamydia vacuole has no classic endocytic or 10 
lysosomal markers, instead it has host cell derived sphingomyelin thought be obtained 11 
by capturing exocytic vesicle trafficking. The Mycobacterium vacuole is a stalled 12 
early endosomal vacuole which, unlike the other bacteria containing vacuoles, does 13 
not traffic into a nuclear or ER localisation but stays located in the periphery of the 14 
cell. The Legionella and Coxiella vacuoles both locate to the ER and establish as ER 15 
compartments, however whilst the Legionella vacuole is a stalled late endocytic 16 
vacuole the Coxiella vacuole fuses with lysosomes and is a lysosomal vacuole. 17 
 18 
 19 
 20 
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Table 1: Conserved bacterial proteases which have a pathogenic function for 
intracellular bacterial pathogens which reside in a vacuole. 
Protease Organism Virulence function 
Lon Salmonella regulation virulence factors, intracellular virulence 
Proteasome Mycobacteria Regulation, protein degradation 
ClpXP Salmonella regulation virulence factors, intracellular virulence 
HtrA Salmonella 
Legionella 
Brucella 
Mycobacterium 
Chlamydia 
animal model virulence and intracellular survival 
 
RseP Mycobacterium regulation of virulence factors 
Tsp Chlamydia 
Brucella 
Host cell immune downregulation 
intracellular survival, animal model virulence 
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Table 2: Specialised Pathogenesis proteases with unique functions for the intracellular niche 
Protease Organism Substrate/Role 
 SseL Salmonella Ikκα to prevent NF-κβ activation 
ChlaDub1  Chlamydia Ikκα to prevent NF-κβ activation 
CPAF Chlamydia Cytoskeleton for structural 
rearrangements, transcriptional 
regulators of immune activation 
MspA/ProA Legionella IL-2, tissue destruction 
Pla Legionella Plasminogen - activation 
Mycosins Mycobacteria Unknown, bacterial cell wall 
maintenance? Host cell targets? 
Rv2224c Mycobacteria GroEL cleavage and resistance to 
immune compounds 
Rv3671c  Mycobacteria Acid resistance 
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